Background Colon cancer is one of the most common tumors in the digestive tract. Studies of left-side colon cancer (LCC) and right-side colon cancer (RCC) show that these two subtypes have different prognoses, outcomes, and clinical responses to chemotherapy. Therefore, a better understanding of the importance of the clinical classifications of the anatomic subtypes of colon cancer is needed. Methods We collected colon cancer patients’ transcriptome data, clinical information, and somatic mutation data from the Cancer Genome Atlas (TCGA) database portal. The transcriptome data were taken from 390 colon cancer patients (172 LCC samples and 218 RCC samples); the somatic mutation data included 142 LCC samples and 187 RCC samples. We compared the expression and prognostic differences of LCC and RCC by conducting a multi-omics analysis of each using the clinical characteristics, immune microenvironment, transcriptomic differences, and mutation differences. The prognostic signatures was validated using the internal testing set, complete set, and external testing set (GSE39582). We also verified the independent prognostic value of the signature. Results The results of our clinical characteristic analysis showed that RCC had a significantly worse prognosis than LCC. The analysis of the immune microenvironment showed that immune infiltration was more common in RCC than LCC. The results of differential gene analysis showed that there were 360 differentially expressed genes, with 142 upregulated genes in LCC and 218 upregulated genes in RCC. The mutation frequency of RCC was generally higher than that of LCC. BRAF and KRAS gene mutations were the dominant genes mutations in RCC, and they had a strong mutual exclusion with APC, while APC gene mutation was the dominant gene mutation in LCC. This suggests that the molecular mechanisms of RCC and LCC differed. The 4-mRNA and 6-mRNA in the prognostic signatures of LCC and RCC, respectively, were highly predictive and may be used as independent prognostic factors. Conclusion The clinical classification of the anatomic subtypes of colon cancer is of great significance for early diagnosis and prognostic risk assessment. Our study provides directions for individualized treatment of left and right colon cancer.
Background:Colon cancer is one of the common tumors of digestive tract. Studies of left-side colon cancer(LCC) and right-side colon cancer(RCC) show that these two subtypes had different prognosis, outcomes, and clinical response to chemotherapy. Therefore,it is necessary to explore the necessity of clinical classification of anatomic subtypes about colon cancer.Methods:We selected the transcriptome data, clinical information and somatic mutation data of colon cancer patients from the the Cancer Genome Atlas(TCGA )database portal.The transcriptome data included 390 colon cancer patients(172 LCC samples and 218 RCC samples),and the somatic mutation data included 142 LCC samples and 187 RCC samples.By conducting a multi-omics analysis of the LCC and RCC from the four aspects of clinical characteristics, immune microenvironment , transcriptomic differences and mutation differences, so as to compare the expression and prognosis difference of LCC and RCC.We are the first to construct prognostic signatures respectively for LCC and RCC respectively.The prognostic signatures is validated by internal testing set, complete set and external testing set(GSE39582).Additionally we also verified the independent prognostic value of the signature.Results:Clinical characteristics analysis results show that RCC had a significantly worse prognosis than LCC.Analysis the immune microenvironment analysis shows that RCC was more immune infiltration than LCC.The results of differential gene analysis showed that there were 360 differential expressed genes,with 142 up genes in LCC and 218 up genes in RCC.Correlation analysis of mutated genes showed that the expression of mutated genes in RCC was negatively correlated, while the expression of mutated genes in LCC was positively correlated, and the mutation frequency of RCC was generally higher than that of LCC.Meanwhile, our 4-mRNA LCC and 6-mRNA RCC prognostic signatures are highly predictive and can be used as independent prognostic factors.Conclusion:The clinical classification of anatomic subtypes of colon cancer is of great significance for its early diagnosis and prognostic risk assessment.Our study provides directions for individualized treatment of left and right colon cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.